Finvest
BHF Insurance · Annuities · Life insurance · Merger arbitrage · Thesis updated July 1, 2026

A merger bet, not a normal insurer bet

01 Running thesis

The deal is the story

Brighthouse is no longer a simple standalone insurance call. On November 6, 2025, it agreed to be bought by Aquarian for $70.00 per share in cash. Shareholders approved the deal on February 12, 2026, and the HSR antitrust waiting period has expired. The company still says the merger is expected to close in 2026.

The bull case is direct: regulators approve the change of control, FINRA signs off on Brighthouse Securities, and shareholders receive the cash price. That would make day-to-day earnings less important than closing timing.

The bear case is also direct. A state insurance regulator in Delaware, New York, or Massachusetts, or FINRA, could delay or block the deal. A material adverse effect before closing could also give the buyer a way out. If that happens, the stock would likely reset from merger-arbitrage pricing back toward a standalone insurer with capital and ratings questions.

The open question is not whether Brighthouse has a real business. It does. The question is whether any regulator sees a problem with Aquarian taking control of a large annuity and life insurer.

May 2026The Q1 2026 10-Q did not change the thesis. Brighthouse still expects the merger to close in 2026, subject to insurance regulatory approvals.
Feb 2026The 2025 10-K confirmed two key deal milestones: shareholders approved the merger on February 12, 2026, and the HSR waiting period expired. The main remaining gates are state insurance approvals and FINRA.
Nov 2025The thesis shifted to an event-driven merger case after Brighthouse agreed to be acquired by Aquarian for $70.00 per share in cash. Standalone operating debates became secondary to deal closing risk.
Aug 2025S&P downgraded key ratings, including financial strength ratings for certain insurance subsidiaries to A from A+. That added weight to the bear case around capital and financial strength.
May 2025Brighthouse disclosed a $100 million capital contribution from the parent to its main insurance subsidiary. That raised concern that capital pressure was worse than the prior bull case assumed.
Feb 2025The 2024 10-K showed a combined RBC ratio of about 400%, the low end of the target range. It also disclosed negative ratings outlooks from Fitch and A.M. Best.
Feb 2025Management said the year-end 2024 RBC ratio was about 400% after a $100 million holding company contribution. It also said the plan called for a relatively stable RBC ratio without more holding company support.
Nov 2024The Q3 2024 call disclosed an estimated combined RBC ratio of 365% to 385%, below target. Management tied much of the pressure to strong Shield annuity sales and pointed to reinsurance and hedging changes as fixes.
02 Business model

Fees, spreads, and insurance risk

Brighthouse makes money in three main ways. It earns fees on annuity and life policies, including asset-based fees on variable annuities. It earns investment spread, which is the gap between what its investment portfolio earns and what it credits to policyholders. It also earns or loses money from insurance activity, meaning premiums compared with benefits and claims.

The biggest profit engine is Annuities. In Q1 2026, Annuities produced $324 million of adjusted earnings. That segment includes variable annuities, fixed annuities, and Shield products, which are index-linked annuities that offer some market exposure with downside protection features.

This model can break when markets move sharply. Brighthouse uses hedges to manage promises tied to variable annuity and Shield products, but GAAP results can still swing. In Q1 2026, the company reported a $792 million net loss available to common shareholders, while adjusted earnings were $239 million.

Capital matters because insurers must hold enough statutory capital to support promises to policyholders. Before the merger became the main issue, Brighthouse had pressure here. Its combined RBC ratio was about 400% at year-end 2024, the low end of its target range, and the company made a $100 million capital contribution to its main insurance subsidiary in 2025.

03 Product portfolio

Retirement products with long tails

Cash cow

Variable annuities with guarantees

These products give customers market-linked retirement exposure plus guarantees such as minimum benefits. They can produce fee income, but they also create hedge and capital risk when markets move.

Growth engine

Shield Level Annuities

Shield is Brighthouse's index-linked annuity family. The company launched updated versions in July 2024 and manages newer Shield business separately from older variable annuity and first-generation Shield blocks.

Steady

Fixed annuities

Fixed annuities are spread products. Brighthouse earns the difference between investment income and the rate credited to policyholders.

Steady

Universal life insurance

The Life segment includes universal life and other life products. These products can provide steady policy fees, but results depend on claims, policyholder behavior, and investment returns.

Option

Universal life with secondary guarantees

ULSG is mainly part of the Run-off segment, meaning Brighthouse manages it but does not focus on new sales. It can be sensitive to interest rates, claims, and reserve assumptions.

Steady

Legacy run-off blocks

Run-off includes older life and annuity products that are no longer actively sold. These blocks can free capital over time, but they can also surprise investors if claims or assumptions move the wrong way.

04 Business segments

Annuities dominate the mix

Annuities52%modest
Life16%declining
Run-off23%modest
Corporate & Other9%declining

The segment mix uses Q1 2026 total revenues from the latest 10-Q. Annuities made up a little over half of segment revenue, while adjusted earnings were even more concentrated in Annuities.

05 Risk factors

What can still go wrong

Regulator blocks or delays the merger

High impact · Medium odds

The deal still needs insurance regulatory approvals, including key state approvals tied to the change of control. If Delaware, New York, or Massachusetts rejects the deal or asks for tough conditions, closing could slip or fail.

We watchFormal decisions from Delaware, New York, and Massachusetts insurance regulators.

FINRA approval does not arrive

High impact · Medium odds

Brighthouse also needs approval for the change in control of Brighthouse Securities, LLC. FINRA is a smaller headline than the insurance regulators, but it is still a named closing condition.

We watchFINRA approval for the change in control of Brighthouse Securities, LLC.

Deal break resets the stock

High impact · Medium odds

The current investment case is tied to the $70.00 per share cash consideration. If the merger fails, investors would likely reprice Brighthouse as a standalone insurer again. That would bring back concerns about capital, ratings, hedging, and long-term cash generation.

We watchAny company filing that says the merger will not close on the expected timeline or at all.

A material adverse effect before closing

High impact · Low odds

A serious business, capital, legal, or market event before closing could give the buyer a reason to challenge the deal. The latest filings did not show a new material adverse event, but the risk remains until the deal closes.

We watchNew risk factor updates, sharp statutory capital deterioration, or major litigation disclosures before closing.

Business disruption while waiting

Medium impact · Medium odds

A pending merger can distract employees and unsettle distributors, vendors, and customers. If the deal drags on, Brighthouse may have less room to take normal strategic actions because the merger agreement restricts some business decisions.

We watchDisclosure of employee retention issues, distributor disruption, or unusual sales weakness.

Sunk costs and termination fee exposure

Medium impact · Low odds

Brighthouse has already incurred merger-related costs. If the deal does not close, those costs do not create value for shareholders, and the company may owe a termination fee of about $144 million under certain conditions.

We watchAny termination notice or filing describing fee obligations under the merger agreement.
06 Quick answers

In one breath

What does Brighthouse Financial do?

Brighthouse sells annuities and life insurance in the United States. Its largest business is Annuities, which includes variable, fixed, and index-linked annuity products.

What is the Aquarian deal price for BHF?

Aquarian agreed to buy Brighthouse for $70.00 per share in cash. The deal is expected to close in 2026 if the remaining approvals are received.

What approvals are still needed for the Brighthouse merger?

The main remaining approvals are from insurance regulators, including Delaware, New York, and Massachusetts. FINRA approval is also needed for the change in control of Brighthouse Securities, LLC.

Why can Brighthouse report a net loss while adjusted earnings are positive?

Reported net income includes market moves in hedges, derivatives, and market risk benefits. Adjusted earnings removes some of that market volatility so management can show the operating parts of the business.